All In Biotech

Free tool

FAERS Monitor: Qbrelis

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 208401 or its brand name (Qbrelis, Lisinopril). Reports on generic versions are filed under their own applications.

Reports

297,814

Serious

179,948

60% of reports

Hospitalization

93,925

Death reported

24,314

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue19,506
  • nausea18,031
  • drug ineffective17,342
  • diarrhoea17,024
  • dyspnoea13,566
  • pain13,270
  • dizziness13,181
  • headache12,634
  • off label use10,862
  • vomiting10,679
  • asthenia10,625
  • arthralgia9,421
  • acute kidney injury9,401
  • chronic kidney disease9,006
  • fall8,850

Reports by year received

View as table
YearReports
20042,862
20053,787
20064,148
20074,265
20085,347
20097,302
201010,347
201110,674
201212,559
201312,112
201417,292
201521,708
201622,448
201721,228
201823,130
201922,371
202017,828
202115,520
202215,022
202313,033
202412,476
202513,426
20268,929

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,756,345 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
chronic kidney diseaseSignal9,0069.49.259,500
acute kidney injurySignal9,4014.64.524,674
astheniaSignal10,6252.02.05,450
fall8,8501.91.93,743
dizziness13,1811.91.95,507
diarrhoea17,0241.91.97,116
fatigue19,5061.81.86,874
dyspnoea13,5661.71.74,006
nausea18,0311.61.64,380
vomiting10,6791.61.62,520
arthralgia9,4211.61.62,194
pain13,2701.51.52,511
headache12,6341.41.41,662
drug ineffective17,3420.90.9101
off label use10,8620.90.9201

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.